The Food and Drug Administration (FDA) intends to limit sources for a fixed-price contract to procure Preventative Maintenance and Qualification Services for an Agilent GC/MS and HPLC system. This decision is based on the unique nature of the required services, which only Agilent Technologies or its authorized service provider network can deliver due to the highly specialized nature of the equipment. The contract, part of FDA-RFQ-25-126020, is a Small Business Set Aside under the NAICS Code 811219 for electronic and precision equipment repair. The required services encompass diagnostic tests and replacement of parts compliant with original equipment manufacturer (OEM) specifications, ensuring safe operation of the instruments. The FDA emphasizes that using non-authorized service providers could invalidate warranties and compromise safety and effectiveness. The notice invites other parties capable of meeting this requirement to submit written capability statements, although it is not a request for competitive proposals. The anticipated award is expected within fifteen days after the notice's closing date, emphasizing the urgency and the necessity of specialized services for maintaining the operational standards of FDA’s equipment.